FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387472004: Isoniazid (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461650018 Isoniazid (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481563014 Isoniazid en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1492102012 Isonicotinic acid hydrazide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1492103019 Isonicotinylhydrazide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1492104013 INH en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
58451000195116 isoniazide it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
818961000172113 isoniazide fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
73541000195112 Isoniazid de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Isoniazid (substance) Is a Antituberculosis agent true Inferred relationship Some
Isoniazid (substance) Is a classe d'allergènes false Inferred relationship Some
Isoniazid (substance) Is a allergène médicamenteux false Inferred relationship Some
Isoniazid (substance) Is a Hydrazide antituberculosis agent false Inferred relationship Some
Isoniazid (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antimycobacterial true Inferred relationship Some
Isoniazid (substance) Is a Pyridine and/or pyridine derivative true Inferred relationship Some
Isoniazid (substance) Is a Hydrazine and/or hydrazine derivative true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Accidental isoniazid poisoning Causative agent (attribute) False Isoniazid (substance) Inferred relationship Some
Intentional isoniazid poisoning Causative agent (attribute) False Isoniazid (substance) Inferred relationship Some
intoxication par l'isoniazide d'intention indéterminée Causative agent (attribute) False Isoniazid (substance) Inferred relationship Some 1
Isoniazid adverse reaction (disorder) Causative agent (attribute) True Isoniazid (substance) Inferred relationship Some 1
Isoniazid overdose Causative agent (attribute) True Isoniazid (substance) Inferred relationship Some 1
Accidental isoniazid overdose Causative agent (attribute) True Isoniazid (substance) Inferred relationship Some 1
Intentional isoniazid overdose Causative agent (attribute) True Isoniazid (substance) Inferred relationship Some 1
surdose d'isoniazide d'intention indéterminée Causative agent (attribute) False Isoniazid (substance) Inferred relationship Some 1
Isoniazid 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isoniazid (substance) Inferred relationship Some
Isoniazid 100 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isoniazid (substance) Inferred relationship Some
Isoniazid 50mg/5mL s/f oral solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isoniazid (substance) Inferred relationship Some
Isoniazid 25mg/mL injection solution 2mL ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isoniazid (substance) Inferred relationship Some
Isoniazid 50mg/5mL oral syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isoniazid (substance) Inferred relationship Some
Isoniazid 100mg/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isoniazid (substance) Inferred relationship Some
Isoniazid 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isoniazid (substance) Inferred relationship Some
Isoniazid + pyrazinamide + rifampin 50mg/300mg/120mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isoniazid (substance) Inferred relationship Some
Isoniazid 150 mg and rifampicin 300 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isoniazid (substance) Inferred relationship Some
Poisoning by isoniazid Causative agent (attribute) True Isoniazid (substance) Inferred relationship Some 1
Isonicotinic acid hydrazide measurement Component True Isoniazid (substance) Inferred relationship Some 1
Product containing isoniazid (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 1
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isoniazid (substance) Inferred relationship Some
Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isoniazid (substance) Inferred relationship Some
Product containing isoniazid and rifampicin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 2
Product containing isoniazid and pyrazinamide and rifampicin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 3
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isoniazid (substance) Inferred relationship Some
Isoniazid 100mg/mL injection solution 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isoniazid (substance) Inferred relationship Some
Urine isoniazid measurement (procedure) Component False Isoniazid (substance) Inferred relationship Some 2
Ethambutol hydrochloride+isoniazid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isoniazid (substance) Inferred relationship Some
Accidental isoniazid poisoning Causative agent (attribute) True Isoniazid (substance) Inferred relationship Some 1
Intentional isoniazid poisoning Causative agent (attribute) True Isoniazid (substance) Inferred relationship Some 1
Allergy to isoniazid Causative agent (attribute) False Isoniazid (substance) Inferred relationship Some
Isoniazid +rifampin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isoniazid (substance) Inferred relationship Some
Isoniazid-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 1
Isoniazid-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 1
Allergy to isoniazid Causative agent (attribute) True Isoniazid (substance) Inferred relationship Some 1
Neuropathy caused by isoniazid Causative agent (attribute) True Isoniazid (substance) Inferred relationship Some 1
Product containing isoniazid and rifampicin in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 2
Product containing isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 3
Product containing ethambutol and isoniazid (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 2
Ethambutol- and isoniazid-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 2
Product containing ethambutol and isoniazid and rifampicin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 3
Ethambutol- and isoniazid- and rifampicin-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 3
Product containing ethambutol and isoniazid and pyrazinamide and rifampicin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 4
Product containing ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 4
Isoniazid 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isoniazid (substance) Inferred relationship Some 1
Isoniazid 50 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Isoniazid (substance) Inferred relationship Some 1
Isoniazid 100 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isoniazid (substance) Inferred relationship Some 1
Isoniazid 100 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Isoniazid (substance) Inferred relationship Some 1
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isoniazid (substance) Inferred relationship Some 1
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Isoniazid (substance) Inferred relationship Some 1
Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isoniazid (substance) Inferred relationship Some 1
Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Isoniazid (substance) Inferred relationship Some 1
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isoniazid (substance) Inferred relationship Some 2
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Isoniazid (substance) Inferred relationship Some 2
Isoniazid 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isoniazid (substance) Inferred relationship Some 1
Isoniazid 300 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Isoniazid (substance) Inferred relationship Some 1
Isoniazid 150 mg and rifampicin 300 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Isoniazid (substance) Inferred relationship Some 2
Isoniazid 150 mg and rifampicin 300 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Isoniazid (substance) Inferred relationship Some 2
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Isoniazid (substance) Inferred relationship Some 2
Isoniazid 150 mg and rifampicin 300 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Isoniazid (substance) Inferred relationship Some 1
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Isoniazid (substance) Inferred relationship Some 3
Isoniazid 100 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Isoniazid (substance) Inferred relationship Some 1
Isoniazid 50 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Isoniazid (substance) Inferred relationship Some 1
Isoniazid 150 mg and rifampicin 300 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Isoniazid (substance) Inferred relationship Some 1
Isoniazid 300 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Isoniazid (substance) Inferred relationship Some 1
Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Isoniazid (substance) Inferred relationship Some 1
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Isoniazid (substance) Inferred relationship Some 3
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Isoniazid (substance) Inferred relationship Some 2
Isoniazid 10 mg/mL oral solution This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Isoniazid (substance) Inferred relationship Some 1
Isoniazid 10 mg/mL oral solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Isoniazid (substance) Inferred relationship Some 1
Product containing precisely isoniazid 50 milligram/2 milliliter conventional release solution for injection ampule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Isoniazid (substance) Inferred relationship Some 1
Product containing precisely isoniazid 50 milligram/2 milliliter conventional release solution for injection ampule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Isoniazid (substance) Inferred relationship Some 1
Ethambutol and isoniazid and rifampicin only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 3
Ethambutol and isoniazid only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 2
Ethambutol and isoniazid and pyrazinamide and rifampicin only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 4
Product containing only isoniazid (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 1
Isoniazid and pyrazinamide and rifampicin only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 3
Isoniazid and rifampicin only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 2
Ethambutol and isoniazid and pyrazinamide and rifampicin only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 4
Product containing only ethambutol and isoniazid and rifampicin in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 3
Product containing only isoniazid and rifampicin in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 2
Product containing only ethambutol and isoniazid in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 2
Product containing only isoniazid in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 1
Product containing only isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 3
Product containing only isoniazid in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 1
Product containing precisely isoniazid 25 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Isoniazid (substance) Inferred relationship Some 1
Product containing precisely isoniazid 25 milligram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Isoniazid (substance) Inferred relationship Some 1
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Isoniazid (substance) Inferred relationship Some 3
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Isoniazid (substance) Inferred relationship Some 3
Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Isoniazid (substance) Inferred relationship Some 2
Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Isoniazid (substance) Inferred relationship Some 2
Isoniazid 150 mg and rifampicin 300 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Isoniazid (substance) Inferred relationship Some 2
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Isoniazid (substance) Inferred relationship Some 4
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Isoniazid (substance) Inferred relationship Some 4
Product containing isoniazid and pyridoxine and sulfamethoxazole and trimethoprim (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 3
Product containing only isoniazid and pyridoxine and sulfamethoxazole and trimethoprim (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 3
Isoniazid- and pyridoxine- and sulfamethoxazole- and trimethoprim-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 3
Isoniazid and pyridoxine and sulfamethoxazole and trimethoprim only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Isoniazid (substance) Inferred relationship Some 3
Product containing precisely isoniazid 300 milligram and pyridoxine hydrochloride 25 milligram and sulfamethoxazole 800 milligram and trimethoprim 160 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Isoniazid (substance) Inferred relationship Some 4
Product containing precisely isoniazid 300 milligram and pyridoxine hydrochloride 25 milligram and sulfamethoxazole 800 milligram and trimethoprim 160 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Isoniazid (substance) Inferred relationship Some 4
Isoniazid 75 mg and rifampicin 150 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Isoniazid (substance) Inferred relationship Some 2

Page 1 of 2 End


This concept is not in any reference sets

Back to Start